ANEB — ANEBULO PHARMACEUTICALS INC

Ownership history in 22NW, LP  ·  19 quarters on record

This page tracks every 13F SEC filing in which 22NW, LP reported a position in ANEBULO PHARMACEUTICALS INC (ANEB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
35.68% (2025 Q4)
Avg. % of fund
11.57%
First filed
2021 Q2
Last filed
2025 Q4
Quarters held
19
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 15,467,300 — 0% 35.68% $84.8M $1.01
2025 Q3 UNCHANGED 15,467,300 — 0% 18.22% $38.7M $2.50
2025 Q2 UNCHANGED 15,467,300 — 0% 14.03% $22.3M $1.44
2025 Q1 UNCHANGED 15,467,300 — 0% 13.49% $20.1M $1.30
15 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    ANEB price (monthly, adj. close)

Other funds also holding ANEB

As of 2025 Q4 — sorted by position size

MANGROVE PARTNERS IM, LLC 3Y 7Y 0.21% Nantahala Capital Management, LLC 3Y 7Y 0.1% Rangeley Capital, LLC 0.04% Ikarian Capital, LLC 3Y 0.0% Tower Research Capital LLC (TRC) 3Y 7Y 0.0% RENAISSANCE TECHNOLOGIES LLC 3Y 7Y 0.0% MORGAN STANLEY 3Y 7Y 0.0% GEODE CAPITAL MANAGEMENT, LLC 3Y 7Y 0.0% VANGUARD GROUP INC 3Y 7Y 0.0% CITADEL ADVISORS LLC 3Y 7Y 0.0%
← Back to 22NW, LP Holdings